Dispensarisation of patients after introduction of transjugular intrahepatic portosystemic shunt – diagnostics of shunt dysfunction and the possibilities of intervention

Czech version

Authors: V. Jirkovský ¹; P. Hůlek ^1,2; A. Krajina ³; T. Fejfar ¹; J. Žižka ³; V. Chovanec ³; M. Lojík ³; J. Raupach ³; Š. Šembera ¹; V. Šafka ⁴; T. Vaňásek ¹; O. Renc ³
Authors‘ workplace: II. interní gastroenterologická klinika LF UK a FN Hradec Králové ¹; Interní klinika LF OU, Ostrava ²; Radiologická klinika LF UK a FN Hradec Králové ³; Katedra fyziologie LF UK Hradec Králové ⁴
Published in: Gastroent Hepatol 2014; 68(2): 132-138
Category: Hepatology: Review article

Overview

An article focuses on the overview of dispensarisation of patients after the introduction of transjugular intrahepatic portosystemic shunt mainly from the viewpoint of the diagnostics of shunt dysfunction and the possibilities of its solution.

Key words:
dispensarisation – portal hypertension – transjugular intrahepatic – portosystemic shunt

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.

Submitted:
17. 2. 2014

Accepted:
25. 3. 2014

Sources

1. Haskal ZJ, Pentecost MJ, Soulen MC et al. Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results. Am J Roentgenol 1994; 163(2): 439–444.

2. Lind CD, Malisch TW, Chong WK et al. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1994; 106(5): 1277–1283.

3. Nazarian GK, Ferral H, Castaneda-Zuniga WR et al. Development of stenoses in transjugular intrahepatic portosystemic shunts. Radiology 1994; 192(1): 231–234.

4. Saxon RS, Ross PL, Mendel-Hartvig J et al. Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms. Radiology 1998; 207(3): 683–693.

5. Sterling KM, Darcy MD. Stenosis of transjugular intrahepatic portosystemic shunts: presentation and management. Am J Roentgenol 1997; 168(1): 239–244.

6. Bureau C, Garcia-Pagan JC, Otal P et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126(2): 469–475.

7. Hausegger KA, Karnel F, Georgieva B et al. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol 2004; 15(3): 239–248.

8. Charon JP, Alaeddin FH, Pimpalwar SA et al. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2004; 15(11): 1219–1230.

9. Rossi P, Salvatori FM, Fanelli F et al. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. Radiology 2004; 231(3): 820–830.

10. Saxon RR, Barton RE, Keller FS et al. Prevention, detection and treatment of TIPS stenosis and occlusion. Sem Interv Radiol 1995; 12: 375–383.

11. Jirkovsky V, Fejfar T, Safka V et al. Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency. J Vasc Interv Radiol 2011; 22(1): 55–60. doi: 10.1016/j.jvir.2010.09.016.

12. Krajina A, Lojik M, Chovanec V et al. Stent-grafts in TIPS. Abdom Imaging 2004; 29(1): 53–59.

13. Rössle M, Haag K, Ochs A et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330(3): 165–171.

14. Cejna M, Peck-Radosavljevic M, Schroder M et al. Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in pacients with Budd-Chiari syndrome. J Vasc Iterv Radiol 2002; 13(2 Pt 1): 193–199.

15. Jalan R, Harrison DJ, Redhead DN et al. Transjugular intrahepatic portosystemic stent-shunt (TIPSS) occlusion and the role of biliary venous fistulae. J Hepatol 1996; 24(2): 169–176.

16. LaBerge JM, Ferrell LD, Ring EJ et al. Histopathologic study of stenotic and occluded transjugular portosystemic shunts. J Vasc Interv Radiol 1993; 4(6): 779–786.

17. Sanyal AJ, Contos MJ, Yager D et al. Development of pseudointima and stenosis after transjugular intrahepatic portosystemic shunts: characterization of cell phenotype and function. Hepatology 1998; 28(1): 22–32.

18. Saxon RR, Timmermans HA, Uchida BT et al. Stent-grafts for revision of TIPS stenoses and occlusions: a clinical pilot study. J Vasc Interv Radiol 1997; 8(4): 539–548.

19. Stout LC, Lyon RE, Murray NG et al. Pseudointimal biliary epithelial proliferation and Zahn’s infarct associated with a 6 1/2-month-old transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 1995; 90(1): 126–130.

20. Teng GJ, Bettmann MA, Hoopes PJ et al. Transjugular intrahepatic portosystemic shunt: effect of bile leak on smooth muscle cell proliferation. Radiology 1998; 208(3): 799–805.

21. Teng GJ, Lu Q. Bile leakage during transjugular intrahepatic portosystemic shunt creation: in vitro effect of bile on growth and function of human umbilical vein endothelium. Radiology 2005; 235(3): 867–871.

22. Mattsson EJ, Kohler TR, Vergel SM et al. Increased blood flow induces regression of intimal hyperplasia. Arterioscler Thromb Vasc Biol 1997; 17(10): 2245–2249.

23. Zarins CK, Zatina MA, Giddens DP et al. Shear stress regulation of artery lumen diameter in experimental atherogenesis. J Vasc Surg 1987; 5(3): 413–420.

24. Chovanec V, Krajina A, Skrabkova Z et al. Potential factors influencing TIPS patency (abstract). Cardiovasc Intervent Radiol 2001; 24 (Suppl 1): 137.

25. Darcy M. Evaluation and management of transjugular intrahepatic portosystemic shunts. Am J Roentgenol 2012; 199(4): 730–736.

26. Zizka J, Eliás P, Krajina A et al. Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: a 5-year experience in 216 patients. Am J Roentgenol 2000; 175(1): 141–148.

27. Ferral H, Banks B, Wholey M et al. Techniques for transjugular intrahepatic portosystemic shunt revision. Am J Roentgenol 1998; 171(4): 1041–1047.

28. DiSalle RS, Dolmatch BL. Treatment of TIPS stenosis with ePTFE graft-covered stents. Cardiovasc Intervent Radiol 1998; 21(2): 172–175.

29. Haskal ZJ. Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts. Radiology 1999; 213(3): 759–766.

30. Hůlek P, Krajina A et al. Current practice of TIPS. 1. ed. Hradec Králové: Olga Štambergová 2001: 183–197.

31. Sauer P, Theilmann L, Richter G et al. Phenprocoumon for transjugular intrahepatic portosystemic shunt (TIPS): results of a randomized trial (abstract). Gastroenterology 1995; 108: A1164.

32. Theilmann L, Sauer P, Roeren T et al. Acetylsalicylic acid in the prevention of early stenosis and occlusion of transjugular intrahepatic portal-systemic stent shunts: a controlled study. Hepatology 1994; 20(3): 592–597.

33. Siegerstetter V, Huber M, Ochs A et al. Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment. Hepatology 1999; 29(1): 33–38.

34. Dvorák J, Hůlek P, Raupach J et al. Endovascular brachytherapy of transjugular intrahepatic portosystemic shunt. Cardiovasc Radiat Med 2000; 2(1): 3–6.

35. Pokrajac B, Cejna M, Kettenbach J et al. Intraluminal 192Ir brachytherapy following transjugular intrahepatic portosystemic shunt revision: long-term results and radiotherapy parameters. Cardiovasc Radiat Med 2001; 2(3): 133–137.

36. Park SW, Cha IH, Lee SH et al. Inhibition of pseudointimal hyperplasia in swine TIPS models: the efficacy of local delivery of paclitaxel using a perforated balloon catheter. Br J Radiol 2007; 80(957): 702–707.

37. Cohen GS, Young HY, Ball DS. Stent-graft as treatment for TIPS-biliary fistula. J Vasc Interv Radiol 1996; 7(5): 665–668.

38. Beheshti MV, Dolmatch BL, Jones MP. Technical considerations in covering and deploying a Wallstent endoprosthesis for the salvage of a failing transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 1998; 9(2): 289–293.

39. Boyvat F, Cekirge S, Balkanci F et al. Treatment of a TIPS-biliary fistula by stent-graft in a 9-year-old boy. Cardiovasc Intervent Radiol 1999; 22(1): 67–68.

40. Haskal ZJ, Weintraub JL, Susman J. Recurrent TIPS thrombosis after polyethylene stent-grafts use and salvage with polytetrafluoroethylene stent-grafts. J Vasc Interv Radiol 2002; 13(12): 1255–1259.

41. Patel NH, McLennan G, Shah H. Introduction of a ePTFE-covered long, spiral-articulated Palmaz stent through a 10-F sheat using umbilical wrapping technique. J Vasc Interv Radiol 1999; 10(8): 1063–1066.

42. Sze DY, Vestring T, Liddell RP et al. Recurrent TIPS failure associated with biliary fistulae: treatment with PTFE-covered stents. Cardiovasc Intervent Radiol 1999; 22(4): 298–304.

43. Andrews RT, Saxon RR, Bloch RD. Stent-grafts for de novo TIPS: technique and early results. J Vasc Interv Radiol 1999; 10(10): 1371–1378.

44. Cejna M, Peck-Radosavljevic M, Thurnher SA et al. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis. Radiology 2001; 221(2): 437–446.

45. Otal P, Smayra T, Bureau C et al. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. Am J Roentgenol 2002; 178(1): 141–147.

46. Perarnau JM, Le Gouge A, Nicolas C et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: A randomized controlled trial. J Hepatol 2014. doi: 10.1016/j.jhep.2014.01.015.